Does lupus or arthritis affect your prognosis if you get COVID-19?
Soon after the coronavirus pandemic began, we learned that older adults and people with certain chronic conditions, such as high blood pressure or diabetes, are at increased risk for severe COVID-19. One condition on that list is an immunocompromised state (a weakened immune system). This can be due to a number of conditions, including having had an organ transplant, having HIV, or taking medications that suppress the immune system.
If you have an autoimmune condition such as rheumatoid arthritis or lupus (also called systemic lupus erythematosus), you may wonder how this affects your risk. It’s thought that these condit...
Source: Harvard Health Blog - November 9, 2020 Category: Consumer Health News Authors: Robert H. Shmerling, MD Tags: Autoimmune diseases Bones and joints Coronavirus and COVID-19 Source Type: blogs
Living with Crohn ’s disease: Recognizing and managing flares
Crohn’s disease is an inflammatory condition that can affect any part of the gastrointestinal tract. Together with ulcerative colitis, Crohn’s is one of the two main types of inflammatory bowel disease (IBD). Crohn’s affects approximately 500,000 Americans and is a chronic, lifelong condition that typically alternates between periods of relatively stable or absent symptoms (remission) and periods of symptom flare-ups that can last for days, weeks, or even months.
The goal of treatment is to induce remission and then to maximize the chance that patients stay in remission. However, almost everyone with Crohn’s diseas...
Source: Harvard Health Blog - November 26, 2019 Category: Consumer Health News Authors: John Garber, MD Tags: Digestive Disorders Health Source Type: blogs
Could that rash be from wheat?
Grains can play havoc with your skin. The prolamin proteins, such as gliadin, trigger autoimmune skin reactions and turn antibodies against the skin enzymes, their lectins fan the fires of inflammation, their proteins provoke allergies, and their amylopectins send blood sugar and insulin sky-high and provoke the skin-disrupting hormone insulin-like growth factor-1 (IGF). The whole grain package adds up to an impressive collection of skin conditions that can take a variety of forms, from simple red, itchy rashes to scaly, oily raised patches to large vesicles to gangrene. Because hair and nails are also considere...
Source: Wheat Belly Blog - February 20, 2019 Category: Cardiology Authors: Dr. Davis Tags: News & Updates Source Type: blogs
Are Grains to Blame for That Rash Too?
Grains can play havoc with your skin. The prolamin proteins, such as gliadin, trigger autoimmune skin reactions and turn antibodies against the skin enzymes, their lectins fan the fires of inflammation, their proteins provoke allergies, and their amylopectins send blood sugar and insulin sky-high and provoke the skin-disrupting hormone insulin-like growth factor-1 (IGF). The whole grain package adds up to an impressive collection of skin conditions that can take a variety of forms, from simple red, itchy rashes to scaly, oily raised patches to large vesicles to gangrene. Because hair and nails are also considere...
Source: Wheat Belly Blog - February 20, 2019 Category: Cardiology Authors: Dr. Davis Tags: News & Updates Source Type: blogs
Tammy Talks About Her Wheat Belly Success
I previously shared Tammy’s Wheat Belly success story that illustrates just how far you can take back health and reverse numerous chronic health conditions. Besides losing over 70 pounds in weight, she also:
Reversed type 2 diabetes, reducing HbA1c from the diabetic range of 8.4% to 4.9%—an ideal level.
Reversed hypertension
Reversed gastroesophageal reflux
Reversed irritable bowel syndrome
Reversed rheumatoid arthritis
She has also been able to discontinue a list of toxic medications, including metformin, Prilosec, and Remicade. And, as you can readily see, turned the clock back 20 years in appearance...
Source: Wheat Belly Blog - December 3, 2018 Category: Cardiology Authors: Dr. Davis Tags: News & Updates autoimmune blood sugar diabetes gastroesphageal gerd Gliadin gluten gluten-free grain-free grains high blood pressure hypertension Inflammation irritable bowel its Weight Loss wheat belly Source Type: blogs
Tammy turns the clock back 20+ years living the Wheat Belly lifestyle
Not only did Tammy turn the clock back on aging and appearance by at least 20 years, she also lost 70+ pounds, reversed decades of rheumatoid arthritis, type 2 diabetes, hypertension, and gastroesophageal reflux.
“My doctor had me start following Wheat Belly in January. I was diagnosed with rheumatoid arthritis 24 yrs ago and ran the gamut of methotrexate to Remicade infusions, steroids—you name it. I no longer have to take anything and my inflammatory markers are lower than they ever were.
“My A1c was 8.4 and is now 4.9. I no longer have GERD. My BP has stabilized and the only real medicine I am currentl...
Source: Wheat Belly Blog - November 30, 2018 Category: Cardiology Authors: Dr. Davis Tags: News & Updates anti-aging antiaging Inflammation Weight Loss wheat belly younger youth restoration Source Type: blogs
Fight Aging! Newsletter, April 30th 2018
In conclusion, in the Framingham Heart Study population, in the last 30 years, disease duration in persons with dementia has decreased. However, age-adjusted mortality risk has slightly decreased after 1977-1983. Consequences of such trends on dementia prevalence should be investigated.
Recent Research on the Benefits of Exercise in Later Life
https://www.fightaging.org/archives/2018/04/recent-research-on-the-benefits-of-exercise-in-later-life/
A sizable body of work points to the ability of older individuals to continue to obtain benefits through regular physical activity, and particularly in the case...
Source: Fight Aging! - April 29, 2018 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Cornelis (Cees) Wortel, Ichor Therapeutics Chief Medical Officer, on Rejuvenation Research and Its Engagement with the Established Regulatory System
Ichor Therapeutics is the most mature of the US-based companies that have emerged from the SENS rejuvenation research community in recent years. You might recall a number of interviews back in the Fight Aging! Archives with founder and CEO Kelsey Moody. He has his own take on how our community should proceed from laboratory to clinic: he is very much in favor of demonstrating (a) that the formal regulatory path offered by the FDA can work for the treatment of aging, and (b) that - given the right strategic approach - rejuvenation therapies can attract the attention, collaboration, and backing of Big Pharma entities in the ...
Source: Fight Aging! - April 23, 2018 Category: Research Authors: Reason Tags: Healthy Life Extension Community Source Type: blogs
The momentum to treat in America is unmatched around the globe
An excerpt from At Peace: Choosing a Good Death After a Long Life. Copyright © 2018 by Samuel Harrington, MD. Reprinted with permission of Grand Central Publishing. All rights reserved.
The momentum to treat in America is unmatched around the globe or throughout history. As a result, we spend twice as much on medical care as the next most expensive country. A very large percentage of that money is spent in the last six months of life.
What fuels the momentum to treat? American exceptionalism, for one. This is an ingrained feeling that the United States and its citizens are not only different but are the best, have the b...
Source: Kevin, M.D. - Medical Weblog - April 14, 2018 Category: General Medicine Authors: < a href="https://www.kevinmd.com/blog/post-author/samuel-harrington" rel="tag" > Samuel Harrington, MD < /a > Tags: Physician Geriatrics Hospital-Based Medicine Primary Care Source Type: blogs
FDA Approves Sixth United States Biosimilar
Recently, the FDA announced that it approved Boehringer Ingelheim’s Cyltezo (adalimumab-adbm), the second biosimilar to AbbVie’s blockbuster Humira and sixth biosimilar in the United States. “Cyltezo is the first biosimilar from Boehringer Ingelheim to be approved by the FDA and marks an important step towards our goal of providing new and more affordable treatment options to healthcare providers and patients,” said Ivan Blanarik, Senior Vice President and Head of Therapeutic Area Biosimilars at Boehringer Ingelheim. “Chronic inflammatory diseases collectively affect 23.5 million people in the U.S., and Cyltezo h...
Source: Policy and Medicine - November 17, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs
Cardiology MCQ Test 5
Time limit: 0
Quiz-summary
0 of 20 questions completed
Questions:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
...
Source: Cardiophile MD - October 22, 2017 Category: Cardiology Authors: Johnson Francis Tags: General Cardiology Source Type: blogs
MKSAP: 28-year-old man is evaluated for recurrent nephrolithiasis
Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians.
A 28-year-old man is evaluated for recurrent nephrolithiasis. Medical history is significant for Crohn disease complicated by multiple small bowel strictures requiring resection. He began developing kidney stones 3 years ago following his last bowel surgery. Analysis of the stones has consistently shown calcium oxalate, and he has been adherent to a low oxalate diet, oral hydration to maintain urine output of at least 2 L/d, and intake of 2 g of calcium carbonate with each meal. However, he has continued to have...
Source: Kevin, M.D. - Medical Weblog - May 13, 2017 Category: General Medicine Authors: < a href="http://www.kevinmd.com/blog/post-author/mksap" rel="tag" > mksap < /a > Tags: Conditions Nephrology Source Type: blogs
Antidote for dabigatran – Cardiology MCQ
Which of the following is an antidote for dabigatran?
a) Abciximab
b) Idarucizumab
c) Infliximab
d) None of the above
Correct answer: b) Idarucizumab
Abciximab is an antiplatelet agent (glycoprotein Iib/IIIa antagonist) and infliximab is a tumor necrosis factor alpha (TNF-α) antagonist used in the treatment of autoimmune disorders. (Source: Cardiophile MD)
Source: Cardiophile MD - March 9, 2017 Category: Cardiology Authors: Johnson Francis Tags: Cardiology MCQ DM / DNB Cardiology Entrance Source Type: blogs
2017 Biosimilar Update
We have taken an interest in the growing biosimilars market in the United States. Recently, we covered the Friends of Cancer Research event, “The Future of the U.S. Biosimilars Market: Development, Education, and Utilization,” a half-day forum that brought together clinicians, originator and biosimilar drug sponsors, advocates, regulators, and payers in an attempt to tackle uncertainty surrounding the future of the United States biosimilars market. With now several biosimilars approved in the United States, there is an ever-growing interest in their approvals and further development. But heading into a new year, uncert...
Source: Policy and Medicine - February 7, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs
Updated Medicare and Medicaid Drug Spending Data Released
On November 15, 2016, the Centers for Medicare and Medicaid Services (CMS) released updated Medicare and Medicaid drug spending data, to include information for calendar year (CY) 2015 through its online interactive dashboards for Medicare and Medicaid. The inclusion of the Medicaid drug spending data on the public dashboard is new this year, as is the addition of high-level (aggregated) Medicare drug rebate data.
CMS noted that “there is significant growth in spending on prescription drugs, representing a significant burden.” In CY 2015, total prescription drug costs amounted to roughly $457 billion – an estimated ...
Source: Policy and Medicine - December 14, 2016 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs
